Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Banyu claims new series of piperidine chemokine antagonists

Oct. 27, 2000

Hepatic metabolism of ciclesonide discussed at Xenobiotics meeting in Japan

Oct. 27, 2000

Dainippon describes new, water-soluble neutrophil elastase inhibitors

Oct. 26, 2000

Retinoid antagonists and their use described in recent patent by Roche

Oct. 24, 2000

Imidazole-based H3 receptor antagonists and their use patented by Schering-Plough

Oct. 23, 2000

Coley begins phase II trials with CpG compound

Oct. 23, 2000

NIH grant for acute lung injury research goes to CollaGenex

Oct. 23, 2000

SB reports discovery of CCR3 receptor antagonists and potential applications thereof

Oct. 20, 2000

Elan receives patent coverage for new integrin receptor antagonists

Oct. 19, 2000

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...